We would like to highlight a trial that is looking at a novel way of treating Graves’ hyperthyroidism (Graves’ disease) in the young.

The trial involves giving a single dose of a medicine called Rituximab on the basis that it may increase the number of individuals whose hyperthyroidsm settles or goes away following a short course of standard anti-thyroid drug treatment with carbimazole.

If you would like further details please contact tim.cheetham@nuth.nhs.uk (alternative email address t.d.cheetham@ncl.ac.uk).